Corpus Intelligence IC Memo — AVERA FLANDREAU HOSPITAL 2026-04-26 06:41 UTC
IC Memo — AVERA FLANDREAU HOSPITAL
Investment Committee Memorandum | SD | 18 beds | Grade C | EBITDA uplift $796K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AVERA FLANDREAU HOSPITAL

CCN 431310 | MOODY, SD | 18 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

AVERA FLANDREAU HOSPITAL is a 18-bed rural/critical access in MOODY, SD with $10.7M in net patient revenue and a 13.8% operating margin. The hospital serves a payer mix of 61.3% Medicare, 3.3% Medicaid, and 35.4% commercial.

Thesis: Turnaround. Our ML models identify $796K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.8% to 21.2% (+741bps).

Net Revenue HCRIS$10.7M
Current EBITDA COMPUTED$1.5M
Operating Margin COMPUTED13.8%
Occupancy HCRIS12.0%
Revenue / Bed COMPUTED$597K
Net-to-Gross HCRIS50.2%
Distress Probability ML60.9%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
40
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of 13.8% places it above the state median. Among 40 size-comparable peers (9-36 beds), the median margin is -1.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 40 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AVERA FLANDREAU HOSPITAL (Target)SD18$10.7M13.8%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%
BLACK HILLS SURGICAL HOSPITAL SD26$91.1M15.3%
HURON REGIONAL MEDICAL CENTERSD25$49.4M-5.9%
MONUMENT HEALTH STURGIS REGIONSD25$39.1M-3.3%
MADISON REGIONAL HEALTH SYSTEMSD22$33.8M-1.6%
SANFORD MEDICAL CENTER VERMILLSD25$32.0M8.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $796K (741bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$226K+210bp18mo
Denial Rate Reduction12.0%6.5%$215K+200bp12mo
Cost to Collect4.5%2.5%$215K+200bp12mo
A/R Days Reduction5200.0%3800.0%$131K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+9bp6mo

5. EBITDA Bridge

Net Collection Rate
$226K
Denial Rate Reduction
$215K
Cost to Collect
$215K
A/R Days Reduction
$131K
Clean Claim Rate
$10K
Total EBITDA Uplift$796K
Current EBITDA$1.5M
+ RCM Uplift+$796K
Pro Forma EBITDA$2.3M
Current Margin13.8%
Pro Forma Margin21.2%
WC Released (1x)$412K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.3M$17.7M7.78x50.7%
Base (11x exit)10.0x11.0x$2.3M$20.2M8.89x54.8%
Bull Case9.0x11.0x$2.0M$23.6M11.52x63.0%
Bull (12x exit)9.0x12.0x$2.0M$26.3M12.86x66.7%
Bear Case11.0x10.0x$2.5M$13.0M5.19x39.0%
Bear (11x exit)11.0x11.0x$2.5M$15.1M6.04x43.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 61.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 12.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 60.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 40 hospitals with 9-36 beds
  • Same-state prioritization (n=41)
  • Comp margins: P25=-9.0% / P50=-1.6% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.